These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5933940)

  • 1. Clinical-laboratory experiences with combined dried live measles-smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Hilleman MR; Grunmeier PW
    Pediatrics; 1966 Jun; 37(6):913-20. PubMed ID: 5933940
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical laboratory experiences with a more attenuated Enders' measles virus vaccine (Moraten) combined with smallpox vaccine.
    Weibel RE; Stokes J; Buynak EB; Leagus MB; Hilleman MR
    Pediatrics; 1969 Apr; 43(4):567-72. PubMed ID: 4304934
    [No Abstract]   [Full Text] [Related]  

  • 3. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 4. [Comparative study of the immunogenic activity of 2 variants of the measles virus].
    Chiarini A; Brancato P; Sinatra A
    Riv Ist Sieroter Ital; 1968; 43(4):175-88. PubMed ID: 5747129
    [No Abstract]   [Full Text] [Related]  

  • 5. [Virologic and clinical observations after active measles vaccination. 2].
    Haas R; Vivell O; Buentello-Malo L; Reiss G; Berning D
    Dtsch Med Wochenschr; 1966 Apr; 91(13):569-74. PubMed ID: 5930702
    [No Abstract]   [Full Text] [Related]  

  • 6. Observation of the protective effect of live measles vaccines in the first year after vaccination.
    Sejda J; Helcl J; Strauss J
    J Hyg Epidemiol Microbiol Immunol; 1966; 10(3):288-95. PubMed ID: 4161911
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccination against measles: a clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. A report to the Medical Research Council by the Measles Vaccines Committee.
    Br Med J; 1966 Feb; 1(5485):441-6. PubMed ID: 5902680
    [No Abstract]   [Full Text] [Related]  

  • 8. [Combined measles-smallpox vaccination].
    Ristori C; Boccardo H; Borgoño JM; Greiber R; Heras E; Carrillo B; Ramírez A; Guzmán E
    Bol Oficina Sanit Panam; 1969 Oct; 67(4):322-7. PubMed ID: 4242000
    [No Abstract]   [Full Text] [Related]  

  • 9. RESPONSE OF VOLTA CHILDREN TO JET INOCULATION OF COMBINED LIVE MEASLES, SMALLPOX AND YELLOW FEVER VACCINES.
    MEYER HM; HOSTETLER DD; BERNHEIN BC; ROGERS NG; LAMBIN P; CHASSARY A; LABUSQUIERE R; SMADEL JE
    Bull World Health Organ; 1964; 30(6):783-94. PubMed ID: 14215185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological survey of measles immunization with the Rimevax--RIT--vaccine in a Romanian district.
    Ciufecu E; Dincă L; Serbănescu R; Dinculescu M; Găleşanu M
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):31-40. PubMed ID: 6996640
    [No Abstract]   [Full Text] [Related]  

  • 11. IMMUNIZATION WITH INACTIVATED MEASLES VIRUS VACCINE.
    GARD S; CARLSTROEM G; LAGERCRANTZ R; NORRBY E
    Arch Gesamte Virusforsch; 1965; 16():315-23. PubMed ID: 14322885
    [No Abstract]   [Full Text] [Related]  

  • 12. Attenuated measles virus vaccine dosage study in Central Africa.
    Rosenbloom AL; Taylor M; Casey HL
    J Trop Med Hyg; 1970 Aug; 73(8):183-5. PubMed ID: 5492298
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological consideration of revaccination].
    Takeuchi K
    Nihon Shonika Gakkai Zasshi; 1969 Oct; 73(10):1616-26. PubMed ID: 5390798
    [No Abstract]   [Full Text] [Related]  

  • 14. MEASLES VACCINATION. II. ANTIBODY TITERS 8 TO 9 MONTHS AFTER VACCINATION WITH AN INACTIVATED VACCINE.
    NORRBY E; CARLSTROEM G; LAGERCRANTZ R; GARD S
    Acta Paediatr (Stockh); 1964 Nov; 53():533-40. PubMed ID: 14225879
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on further attenuated live measles vaccine. 3. Selection of less reactive variants of CAM measles vaccine virus.
    Takaku K; Sasada T; Konobe T; Onishi K; Ueda S
    Biken J; 1970 Sep; 13(3):163-8. PubMed ID: 5530510
    [No Abstract]   [Full Text] [Related]  

  • 16. Durability of antibodies induced by inactivated measles virus vaccine.
    Masuno S; Kaneko T; Arakawa S
    Zentralbl Bakteriol Orig; 1968 Apr; 206(3):353-60. PubMed ID: 5707315
    [No Abstract]   [Full Text] [Related]  

  • 17. [Measles vaccination: study of humoral immunity in children vaccinated in the Tunis region].
    Arrouji A; Mirchamsy H; Marnissi A
    Arch Inst Pasteur Tunis; 1982 Mar; 59(1):173-80. PubMed ID: 7181563
    [No Abstract]   [Full Text] [Related]  

  • 18. The persistence of complement fixing and haemagglutination-inhibition antibodies after smallpox infection and after smallpox vaccination.
    Siennicki W; Oleś A; Kocielska W
    J Hyg Epidemiol Microbiol Immunol; 1967; 11(1):27-31. PubMed ID: 6070331
    [No Abstract]   [Full Text] [Related]  

  • 19. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 20. Field evaluation of combined more attenuated live measles (Moraten)-smallpox vaccine in Honduras and Costa Rica.
    Villarejos VM; Rodríguez-Aragonés A; Gúnera N; Arguedas JA; Buynak EB; Hilleman MR
    Am J Epidemiol; 1971 May; 93(5):384-91. PubMed ID: 5556398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.